Review re-maps multi-view learning into four supervised scenarios and three granular sub-tiers, delivering the first unified ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...